| Year |
Citation |
Score |
| 2024 |
Wannan CMJ, Nelson B, Addington J, Allott K, Anticevic A, Arango C, Baker JT, Bearden CE, Billah T, Bouix S, Broome MR, Buccilli K, Cadenhead KS, Calkins ME, Cannon TD, et al. Accelerating Medicines Partnership® Schizophrenia (AMP® SCZ): Rationale and Study Design of the Largest Global Prospective Cohort Study of Clinical High Risk for Psychosis. Schizophrenia Bulletin. PMID 38451304 DOI: 10.1093/schbul/sbae011 |
0.324 |
|
| 2024 |
Healy C, Byrne J, Raj Suasi S, Föcking M, Mongan D, Kodosaki E, Heurich-Sevcenco M, Cagney G, Wynne K, Bearden CE, Woods SW, Cornblatt B, Mathalon D, Stone W, Cannon TD, ... ... Cadenhead KS, et al. Differential expression of haptoglobin in individuals at clinical high risk of psychosis and its association with global functioning and clinical symptoms. Brain, Behavior, and Immunity. PMID 38219978 DOI: 10.1016/j.bbi.2023.12.018 |
0.362 |
|
| 2024 |
Voineskos AN, Hawco C, Neufeld NH, Turner JA, Ameis SH, Anticevic A, Buchanan RW, Cadenhead K, Dazzan P, Dickie EW, Gallucci J, Lahti AC, Malhotra AK, Öngür D, Lencz T, et al. Functional magnetic resonance imaging in schizophrenia: current evidence, methodological advances, limitations and future directions. World Psychiatry : Official Journal of the World Psychiatric Association (Wpa). 23: 26-51. PMID 38214624 DOI: 10.1002/wps.21159 |
0.3 |
|
| 2023 |
Bannai D, Reuter M, Hegde R, Hoang D, Adhan I, Gandu S, Pong S, Raymond N, Zeng V, Chung Y, He G, Sun D, van Erp TGM, Addington J, Bearden CE, ... Cadenhead K, et al. Linking enlarged choroid plexus with plasma analyte and structural phenotypes in clinical high risk for psychosis: A multisite neuroimaging study. Brain, Behavior, and Immunity. PMID 38169244 DOI: 10.1016/j.bbi.2023.12.021 |
0.302 |
|
| 2023 |
Caballero N, Machiraju S, Diomino A, Kennedy L, Kadivar A, Cadenhead KS. Recent Updates on Predicting Conversion in Youth at Clinical High Risk for Psychosis. Current Psychiatry Reports. PMID 37755654 DOI: 10.1007/s11920-023-01456-2 |
0.333 |
|
| 2023 |
Worthington MA, Collins MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone WS, Walker EF, Woods SW, Cannon TD. Improving prediction of psychosis in youth at clinical high-risk: pre-baseline symptom duration and cortical thinning as moderators of the NAPLS2 risk calculator. Psychological Medicine. 1-9. PMID 37642172 DOI: 10.1017/S0033291723002301 |
0.351 |
|
| 2023 |
Woods SW, Parker S, Kerr MJ, Walsh BC, Wijtenburg SA, Prunier N, Nunez AR, Buccilli K, Mourgues-Codern C, Brummitt K, Kinney KS, Trankler C, Szacilo J, Colton BL, Ali M, ... ... Cadenhead KS, et al. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS. Early Intervention in Psychiatry. PMID 37641537 DOI: 10.1111/eip.13457 |
0.303 |
|
| 2023 |
Anglin DM, Espinosa A, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone W, Tsuang M, Woods SW, Walker E, Bearden CE, Ku BS. Association of Childhood Area-Level Ethnic Density and Psychosis Risk Among Ethnoracial Minoritized Individuals in the US. Jama Psychiatry. PMID 37585191 DOI: 10.1001/jamapsychiatry.2023.2841 |
0.309 |
|
| 2023 |
Devoe DJ, Lui L, Cannon TD, Cadenhead KS, Cornblatt BA, Keshavan M, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Tsuang MT, Woods SW, Walker EF, Mathalon DH, Bearden CE, et al. The impact of early factors on persistent negative symptoms in youth at clinical high risk for psychosis. Frontiers in Psychiatry. 14: 1125168. PMID 37293402 DOI: 10.3389/fpsyt.2023.1125168 |
0.311 |
|
| 2023 |
Woods SW, Parker S, Kerr MJ, Walsh BC, Wijtenburg SA, Prunier N, Nunez AR, Buccilli K, Mourgues-Codern C, Brummitt K, Kinney KS, Trankler C, Szacilo J, Colton BL, Ali M, ... ... Cadenhead KS, et al. Development of the PSYCHS: Positive SYmptoms and Diagnostic Criteria for the CAARMS Harmonized with the SIPS. Medrxiv : the Preprint Server For Health Sciences. PMID 37205422 DOI: 10.1101/2023.04.29.23289226 |
0.303 |
|
| 2023 |
Amir CM, Kapler S, Hoftman GD, Kushan L, Zinberg J, Cadenhead KS, Kennedy L, Cornblatt BA, Keshavan M, Mathalon DH, Perkins DO, Stone W, Tsuang MT, Walker EF, Woods SW, et al. Neurobehavioral risk factors influence prevalence and severity of hazardous substance use in youth at genetic and clinical high risk for psychosis. Frontiers in Psychiatry. 14: 1143315. PMID 37151981 DOI: 10.3389/fpsyt.2023.1143315 |
0.328 |
|
| 2023 |
Michaels TI, Carrión RE, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Tsuang MT, Walker EF, Woods SW, et al. Ethnoracial discrimination and the development of suspiciousness symptoms in individuals at clinical high-risk for psychosis. Schizophrenia Research. 254: 125-132. PMID 36857950 DOI: 10.1016/j.schres.2023.02.021 |
0.302 |
|
| 2023 |
Tronick LN, Mirzakhanian H, Addington J, Bearden CE, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Stone W, Tsuang MT, Walker EF, Woods SW, Cadenhead KS. Risk of violent behaviour in young people at clinical high risk for psychosis from the North American Prodrome Longitudinal Studies consortium. Early Intervention in Psychiatry. PMID 36627192 DOI: 10.1111/eip.13369 |
0.342 |
|
| 2022 |
Sefik E, Boamah M, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan MS, Mathalon DH, Perkins DO, Stone WS, Tsuang MT, Woods SW, Cannon TD, Walker EF. Sex- and Age-Specific Deviations in Cerebellar Structure and Their Link With Symptom Dimensions and Clinical Outcome in Individuals at Clinical High Risk for Psychosis. Schizophrenia Bulletin. PMID 36394426 DOI: 10.1093/schbul/sbac169 |
0.367 |
|
| 2022 |
Barbato M, Liu L, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone W, Tsuang MT, Walker EF, Woods SW, Cannon TD, et al. Migrant status, clinical symptoms and functional outcome in youth at clinical high risk for psychosis: findings from the NAPLS-3 study. Social Psychiatry and Psychiatric Epidemiology. PMID 36348056 DOI: 10.1007/s00127-022-02383-y |
0.358 |
|
| 2022 |
Duncan E, Roach BJ, Massa N, Hamilton HK, Bachman PM, Belger A, Carrion RE, Johannesen JK, Light GA, Niznikiewicz MA, Addington JM, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, et al. Auditory N100 amplitude deficits predict conversion to psychosis in the North American Prodrome Longitudinal Study (NAPLS-2) cohort. Schizophrenia Research. 248: 89-97. PMID 35994912 DOI: 10.1016/j.schres.2022.07.019 |
0.308 |
|
| 2022 |
Hamilton HK, Roach BJ, Bachman PM, Belger A, Carrión RE, Duncan E, Johannesen JK, Light GA, Niznikiewicz MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, et al. Mismatch Negativity in Response to Auditory Deviance and Risk for Future Psychosis in Youth at Clinical High Risk for Psychosis. Jama Psychiatry. PMID 35675082 DOI: 10.1001/jamapsychiatry.2022.1417 |
0.336 |
|
| 2022 |
Santesteban-Echarri O, Sandel D, Liu L, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Tsuang MT, Walker EF, et al. Family history of psychosis in youth at clinical high risk: A replication study. Psychiatry Research. 311: 114480. PMID 35245743 DOI: 10.1016/j.psychres.2022.114480 |
0.331 |
|
| 2022 |
Braun A, Liu L, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone W, Tsuang MT, Walker EF, Woods SW, Cannon TD, et al. Bullying in clinical high risk for psychosis participants from the NAPLS-3 cohort. Social Psychiatry and Psychiatric Epidemiology. PMID 35113189 DOI: 10.1007/s00127-022-02239-5 |
0.334 |
|
| 2021 |
Worthington MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Keshavan M, Mathalon DH, McGlashan TH, Perkins DO, Stone WS, Tsuang MT, Walker EF, Woods SW, Cannon TD. Individualized Prediction of Prodromal Symptom Remission for Youth at Clinical High Risk for Psychosis. Schizophrenia Bulletin. PMID 34581405 DOI: 10.1093/schbul/sbab115 |
0.31 |
|
| 2021 |
Koutsouleris N, Worthington M, Dwyer DB, Kambeitz-Ilankovic L, Sanfelici R, Fusar-Poli P, Rosen M, Ruhrmann S, Anticevic A, Addington J, Perkins DO, Bearden CE, Cornblatt BA, Cadenhead KS, Mathalon DH, et al. Toward Generalizable and Transdiagnostic Tools for Psychosis Prediction: An Independent Validation and Improvement of the NAPLS-2 Risk Calculator in the Multisite PRONIA Cohort. Biological Psychiatry. PMID 34482951 DOI: 10.1016/j.biopsych.2021.06.023 |
0.332 |
|
| 2021 |
Foss-Feig JH, Guillory SB, Roach BJ, Velthorst E, Hamilton H, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light GA, Niznikiewicz M, Addington JM, Cadenhead KS, Cannon TD, et al. Abnormally Large Baseline P300 Amplitude Is Associated With Conversion to Psychosis in Clinical High Risk Individuals With a History of Autism: A Pilot Study. Frontiers in Psychiatry. 12: 591127. PMID 33633603 DOI: 10.3389/fpsyt.2021.591127 |
0.312 |
|
| 2021 |
Fu EJ, Cadenhead KS. Progress in the Prospective Study of the Schizophrenia Prodrome. Current Psychosis & Therapeutics Reports. 3: 169-174. PMID 21691454 DOI: 10.1007/BF02629450 |
0.397 |
|
| 2020 |
Worthington MA, Walker EF, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Woods SW, Cannon TD. Incorporating cortisol into the NAPLS2 individualized risk calculator for prediction of psychosis. Schizophrenia Research. PMID 33046334 DOI: 10.1016/j.schres.2020.09.022 |
0.301 |
|
| 2020 |
Cadenhead KS, Duncan E, Addington J, Bearden C, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Bauchman P, Belger A, et al. Evidence of Slow Neural Processing, Developmental Differences and Sensitivity to Cannabis Effects in a Sample at Clinical High Risk for Psychosis From the NAPLS Consortium Assessed With the Human Startle Paradigm. Frontiers in Psychiatry. 11: 833. PMID 33005152 DOI: 10.3389/Fpsyt.2020.00833 |
0.344 |
|
| 2020 |
Calkins ME, Woods SW, Bearden CE, Liu L, Moore TM, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Mathalon DH, Keshavan M, et al. Concordance and factor structure of subthreshold positive symptoms in youth at clinical high risk for psychosis. Schizophrenia Research. PMID 32943313 DOI: 10.1016/J.Schres.2020.08.014 |
0.302 |
|
| 2020 |
Fryer SL, Roach BJ, Hamilton HK, Bachman P, Belger A, Carrión RE, Duncan E, Johannesen J, Light GA, Niznikiewicz M, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, et al. Deficits in auditory predictive coding in individuals with the psychosis risk syndrome: Prediction of conversion to psychosis. Journal of Abnormal Psychology. 129: 599-611. PMID 32757603 DOI: 10.1037/abn0000513 |
0.365 |
|
| 2020 |
Kelsven S, de la Fuente-Sandoval C, Achim CL, Reyes-Madrigal F, Mirzakhanian H, Domingues I, Cadenhead K. Immuno-inflammatory changes across phases of early psychosis: The impact of antipsychotic medication and stage of illness. Schizophrenia Research. PMID 32089474 DOI: 10.1016/J.Schres.2020.01.003 |
0.354 |
|
| 2020 |
Worthington MA, Miklowitz DJ, O'Brien M, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. Selection for psychosocial treatment for youth at clinical high risk for psychosis based on the North American Prodrome Longitudinal Study individualized risk calculator. Early Intervention in Psychiatry. PMID 31943807 DOI: 10.1111/Eip.12914 |
0.323 |
|
| 2020 |
Worthington M, Addington J, Bearden C, Cadenhead K, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman L, Tsuang M, Walker E, Woods S, Cannon T. T116. PREDICTION OF REMISSION IN NON-CONVERTING INDIVIDUALS AT CLINICAL HIGH RISK FOR PSYCHOSIS Schizophrenia Bulletin. 46: S274-S275. DOI: 10.1093/Schbul/Sbaa029.676 |
0.388 |
|
| 2020 |
Hamilton H, Roach B, Bachman P, Belger A, Carrion R, Johannesen J, Light G, Niznikiewicz M, Addington J, Bearden C, Cadenhead K, Cornblatt B, McGlashan T, Perkins D, Seidman L, et al. O10.2. DEFICIENT VISUAL ODDBALL STIMULUS PROCESSING PREDICTS PSYCHOSIS ONSET: RESULTS FROM THE NORTH AMERICAN PRODROME LONGITUDINAL STUDY Schizophrenia Bulletin. 46: S24-S25. DOI: 10.1093/Schbul/Sbaa028.056 |
0.376 |
|
| 2019 |
Mahmood Z, Kelsven S, Cadenhead K, Wyckoff J, Reyes-Madrigal F, de la Fuente-Sandoval C, Twamley EW. Compensatory Cognitive Training for Latino Youth at Clinical High Risk for Psychosis: Study Protocol for a Randomized Controlled Trial. Frontiers in Psychiatry. 10: 951. PMID 31998163 DOI: 10.3389/Fpsyt.2019.00951 |
0.396 |
|
| 2019 |
Perkins DO, Olde Loohuis L, Barbee J, Ford J, Jeffries CD, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang M, Walker EF, et al. Polygenic Risk Score Contribution to Psychosis Prediction in a Target Population of Persons at Clinical High Risk. The American Journal of Psychiatry. appiajp201918060721. PMID 31711302 DOI: 10.1176/Appi.Ajp.2019.18060721 |
0.312 |
|
| 2019 |
Allswede DM, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan T, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cannon TD. Characterizing Covariant Trajectories of Individuals at Clinical High Risk for Psychosis Across Symptomatic and Functional Domains. The American Journal of Psychiatry. appiajp201918111290. PMID 31509005 DOI: 10.1176/Appi.Ajp.2019.18111290 |
0.339 |
|
| 2019 |
Hamilton HK, Roach BJ, Bachman PM, Belger A, Carrion RE, Duncan E, Johannesen JK, Light GA, Niznikiewicz MA, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, McGlashan TH, Perkins DO, et al. Association Between P300 Responses to Auditory Oddball Stimuli and Clinical Outcomes in the Psychosis Risk Syndrome. Jama Psychiatry. PMID 31389974 DOI: 10.1001/Jamapsychiatry.2019.2135 |
0.389 |
|
| 2019 |
Chung Y, Allswede D, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, et al. Cortical abnormalities in youth at clinical high-risk for psychosis: Findings from the NAPLS2 cohort. Neuroimage. Clinical. 23: 101862. PMID 31150956 DOI: 10.1016/J.Nicl.2019.101862 |
0.426 |
|
| 2019 |
Foss-Feig JH, Velthorst E, Smith L, Reichenberg A, Addington J, Cadenhead KS, Cornblatt BA, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Stone WS, Keshavan M, Tsuang MT, Walker EF, et al. Clinical Profiles and Conversion Rates Among Young Individuals With Autism Spectrum Disorder Who Present to Clinical High Risk For Psychosis Services. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 30797038 DOI: 10.1016/J.Jaac.2018.09.446 |
0.315 |
|
| 2019 |
LoPilato AM, Goines K, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Mathalon DH, McGlashan TH, Seidman L, Perkins DO, Tsuang MT, Woods SW, Walker EF. Impact of childhood adversity on corticolimbic volumes in youth at clinical high-risk for psychosis. Schizophrenia Research. PMID 30745068 DOI: 10.1016/J.Schres.2019.01.048 |
0.31 |
|
| 2019 |
Chung Y, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, Cannon TD, et al. Adding a neuroanatomical biomarker to an individualized risk calculator for psychosis: A proof-of-concept study. Schizophrenia Research. PMID 30745066 DOI: 10.1016/J.Schres.2019.01.026 |
0.349 |
|
| 2019 |
Martin AS, Johannesen J, Roach B, Hamilton H, Bachman P, Belger A, Carrión R, Duncan E, Light G, Niznikiewicz M, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, et al. S190. Does Cannabis Use Interact With Neurophysiological Vulnerability in the Early Expression of Psychosis and Conversion Status in Clinical High-Risk (CHR) Individuals? Biological Psychiatry. 85: S370-S371. DOI: 10.1016/J.Biopsych.2019.03.941 |
0.387 |
|
| 2019 |
Ramyead A, Roach B, Hamilton H, Addington J, Bachman P, Bearden C, Belger A, Cadenhead K, Cannon T, Carrion R, Cornblatt B, Duncan E, Johannesen J, Light G, McGlashan T, et al. O33. EEG Alpha Event-Related Desynchronization Deficits Predict Conversion to Psychosis in Individuals With the Psychosis Risk Syndrome Biological Psychiatry. 85: S119. DOI: 10.1016/J.Biopsych.2019.03.298 |
0.347 |
|
| 2018 |
Goldsmith DR, Haroon E, Miller AH, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Seidman L, Tsuang M, Woods SW, Walker EF, Perkins DO. Association of baseline inflammatory markers and the development of negative symptoms in individuals at clinical high risk for psychosis. Brain, Behavior, and Immunity. PMID 30496778 DOI: 10.1016/J.Bbi.2018.11.315 |
0.337 |
|
| 2018 |
Ward HB, Lawson MT, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Cornblatt BA, Jeffries CD, Mathalon DH, McGlashan TH, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Perkins DO. Tobacco use and psychosis risk in persons at clinical high risk. Early Intervention in Psychiatry. PMID 30362261 DOI: 10.1111/Eip.12751 |
0.308 |
|
| 2018 |
Cadenhead KS, Minichino A, Kelsven S, Addington J, Bearden C, Cannon TD, Cornblatt BA, Mathalon D, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Yao J, et al. Metabolic abnormalities and low dietary Omega 3 are associated with symptom severity and worse functioning prior to the onset of psychosis: Findings from the North American Prodrome Longitudinal Studies Consortium. Schizophrenia Research. PMID 30249470 DOI: 10.1016/J.Schres.2018.09.022 |
0.329 |
|
| 2018 |
Cao H, Chén OY, Chung Y, Forsyth JK, McEwen SC, Gee DG, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, et al. Cerebello-thalamo-cortical hyperconnectivity as a state-independent functional neural signature for psychosis prediction and characterization. Nature Communications. 9: 3836. PMID 30242220 DOI: 10.1038/S41467-018-06350-7 |
0.326 |
|
| 2018 |
Cao H, McEwen SC, Chung Y, Chén OY, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Carrión RE, Mathalon DH, McGlashan TH, Perkins DO, Belger A, et al. Altered Brain Activation During Memory Retrieval Precedes and Predicts Conversion to Psychosis in Individuals at Clinical High Risk. Schizophrenia Bulletin. PMID 30215784 DOI: 10.1093/Schbul/Sby122 |
0.392 |
|
| 2018 |
Addington J, Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Bearden CE, Mathalon DH, Santesteban-Echarri O, Woods SW. Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis. Psychological Medicine. 1-8. PMID 30176955 DOI: 10.1017/S0033291718002258 |
0.355 |
|
| 2018 |
Chung Y, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, McEwen S, van Erp TGM, Cannon TD, et al. Use of Machine Learning to Determine Deviance in Neuroanatomical Maturity Associated With Future Psychosis in Youths at Clinically High Risk. Jama Psychiatry. PMID 29971330 DOI: 10.1001/Jamapsychiatry.2018.1543 |
0.42 |
|
| 2018 |
Allswede D, Cannon T, Addington J, Bearden C, Cadenhead K, Cornblatt B, Mathalon D, Thomas M, Perkins D, Seidman L, Tsuang M, Walker E, Woods S. S244. CHARACTERIZING OUTCOMES OF CLINICAL HIGH-RISK NON-CONVERTERS USING GROUP-BASED TRAJECTORY MODELING Schizophrenia Bulletin. 44: S422-S422. DOI: 10.1093/Schbul/Sby018.1031 |
0.347 |
|
| 2018 |
Foss-Feig J, Velthorst E, Guillory S, Hamilton H, Roach B, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light G, Niznikiewicz M, Addington J, Cadenhead K, Cannon T, et al. F118. ARCHITECTURE OF PSYCHOSIS SYMPTOMS AND NEURAL PREDICTORS OF CONVERSION AMONG CLINICAL HIGH RISK INDIVIDUALS WITH AUTISM SPECTRUM DISORDER Schizophrenia Bulletin. 44: S266-S266. DOI: 10.1093/Schbul/Sby017.649 |
0.387 |
|
| 2018 |
Woodberry K, Stone WS, Shapiro DI, Chokran CM, Addington J, Bearden C, Cadenhead K, Cannon TD, Cornblatt BA, McGlashan TH, Mathalon DH, Perkins DO, Tsuang MT, Walker EF, Woods SW, et al. O2.8. TRAJECTORIES OF NEUROCOGNITIVE FUNCTIONING OVER TIME IN YOUTH AT CLINICAL HIGH RISK WHO DO AND DO NOT TRANSITION TO PSYCHOSIS Schizophrenia Bulletin. 44: S78-S78. DOI: 10.1093/Schbul/Sby015.198 |
0.353 |
|
| 2018 |
Perkins D, Clark J, Addington J, Beardon C, Cadenhead K, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Seidman L, Tsuang M, Walker E, Woods S. 39.1 DNA METHYLATION OF IMMUNE CELLS IN PERSONS AT CLINICAL HIGH RISK FOR PSYCHOSIS Schizophrenia Bulletin. 44: S62-S62. DOI: 10.1093/Schbul/Sby014.159 |
0.318 |
|
| 2018 |
Velthorst E, Bearden C, Meyer E, Giuliano A, Addington J, Cadenhead K, Cannon T, Cornblatt B, Mcglashan T, Perkins D, Tsuang M, Walker E, Woods S, Seidman L. 24.2 NEUROCOGNITIVE PROFILES IN THE PRODROME TO PSYCHOSIS IN NAPLS-1 Schizophrenia Bulletin. 44: S39-S40. DOI: 10.1093/Schbul/Sby014.097 |
0.349 |
|
| 2018 |
Goldsmith D, Miller A, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Tsuang M, Woods S, Walker E. F236. Association of Baseline Tumor Necrosis Factor and the Development of Negative Symptoms in Individuals at Clinical High Risk for Psychosis Biological Psychiatry. 83: S330-S331. DOI: 10.1016/J.Biopsych.2018.02.850 |
0.378 |
|
| 2017 |
Minichino A, Ando' A, Francesconi M, Salatino A, Delle Chiaie R, Cadenhead K. Investigating the link between drug-naive first episode psychoses (FEPs), weight gain abnormalities and brain structural damages: Relevance and implications for therapy. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 77: 9-22. PMID 28363765 DOI: 10.1016/J.Pnpbp.2017.03.020 |
0.302 |
|
| 2017 |
Chung Y, Haut KM, He G, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, et al. Ventricular enlargement and progressive reduction of cortical gray matter are linked in prodromal youth who develop psychosis. Schizophrenia Research. PMID 28245961 DOI: 10.1016/J.Schres.2017.02.014 |
0.373 |
|
| 2017 |
Minichino A, Francesconi M, Carrión RE, Delle Chiaie R, Bevilacqua A, Parisi M, Rullo S, Bersani FS, Biondi M, Cadenhead K. From neurological soft signs to functional outcome in young individuals in treatment with secondary services for non-psychotic disorders: a path analysis. Psychological Medicine. 1-12. PMID 28052777 DOI: 10.1017/S0033291716003056 |
0.385 |
|
| 2017 |
Deyoe J, Kelsven S, Robles-Guerrero C, Mirzakhanian H, Perez G, Reyes-Madrigal F, Twamley E, de la Fuente-Sandoval C, Cadenhead K. SA103. Compensatory Cognitive Training in High-Risk Latino Youth Schizophrenia Bulletin. 43: S150-S150. DOI: 10.1093/Schbul/Sbx023.101 |
0.329 |
|
| 2017 |
Carrion R, McLaughlin D, Auther A, Addington J, Bearden C, Cadenhead K, Cannon T, Tsuang M, Walker E, Woods SW, Cornblatt B. M118. Functional Capacity: A New Predictor of Role Functioning in Individuals at Clinical High Risk for Psychosis Schizophrenia Bulletin. 43: S253-S253. DOI: 10.1093/Schbul/Sbx022.112 |
0.372 |
|
| 2017 |
Joseph J, Cadenhead K. M57. Gastrointestinal Disease Impact on Antipsychotic Induced Weight Gain in Schizophrenia: Analysis of Randomized Controlled Trials. Schizophrenia Bulletin. 43. DOI: 10.1093/Schbul/Sbx022.054 |
0.316 |
|
| 2017 |
Mirzakhanian H, Sanchez S, Addington J, Bearden C, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods SW, Cadenhead K. 209. Risk of Violence in Attenuated Psychosis Symptoms Syndrome and its Relationship With Symptomology Schizophrenia Bulletin. 43: S106-S107. DOI: 10.1093/Schbul/Sbx021.287 |
0.43 |
|
| 2017 |
Burrell H, Lawson M, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, Jeffries C, Mathalon D, McGlashan T, Seidman L, Tsuang M, Walker E, Woods S, Perkins D. 155. Tobacco Use and Psychosis Risk in Persons at Clinical High Risk Schizophrenia Bulletin. 43: S80-S80. DOI: 10.1093/Schbul/Sbx021.213 |
0.4 |
|
| 2017 |
Auther A, Carrion R, McLaughlin D, Addington J, Bearden C, Cadenhead K, Cannon T, Mathalon D, McGlashan TH, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods S, Cornblatt B. 100. Converging Evidence for Social Functioning Deficits as a Neurodevelopmental Risk Factor in High-Risk Youth Schizophrenia Bulletin. 43: S53-S53. DOI: 10.1093/Schbul/Sbx021.138 |
0.375 |
|
| 2017 |
Hamilton H, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Light G, Niznikiewicz M, Roach B, Addington J, Bearden C, Cadenhead K, Cannon T, Cornblatt B, McGlashan T, et al. 80. Auditory Target Processing Deficits in Individuals at Clinical High Risk for Psychosis Schizophrenia Bulletin. 43: S45-S45. DOI: 10.1093/Schbul/Sbx021.119 |
0.406 |
|
| 2017 |
Cadenhead K, Addington J, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, Woods S. 23. Omega-3 Fatty Acid Versus Placebo in a Clinical High-Risk Sample From the North American Prodrome Longitudinal Studies (NAPLS) Consortium Schizophrenia Bulletin. 43: S16-S16. DOI: 10.1093/Schbul/Sbx021.042 |
0.333 |
|
| 2017 |
Kelsven S, Addington J, Bearden C, Cannon T, Cornblatt B, Mathalon D, McGlashan T, Perkins D, Seidman L, Walker E, Woods S, Cadenhead K. 20. Metabolic Abnormalities and Omega-3 Fatty Acids in Latinos at Clinical High Risk for Psychosis Schizophrenia Bulletin. 43: S14-S15. DOI: 10.1093/Schbul/Sbx021.039 |
0.34 |
|
| 2016 |
Minichino A, Francesconi M, Carrión RE, Bevilacqua A, Parisi M, Rullo S, Ando' A, Biondi M, Delle Chiaie R, Cadenhead K. Prediction of functional outcome in young patients with a recent-onset psychiatric disorder: Beyond the traditional diagnostic classification system. Schizophrenia Research. PMID 28041918 DOI: 10.1016/J.Schres.2016.12.019 |
0.428 |
|
| 2016 |
Francesconi M, Minichino A, Carrión RE, Delle Chiaie R, Bevilacqua A, Parisi M, Rullo S, Bersani FS, Biondi M, Cadenhead K. Psychosis prediction in secondary mental health services. A broad, comprehensive approach to the "at risk mental state" syndrome. European Psychiatry : the Journal of the Association of European Psychiatrists. 40: 96-104. PMID 27992839 DOI: 10.1016/J.Eurpsy.2016.09.002 |
0.368 |
|
| 2016 |
Seidman LJ, Shapiro DI, Stone WS, Woodberry KA, Ronzio A, Cornblatt BA, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Mathalon DH, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, et al. Association of Neurocognition With Transition to Psychosis: Baseline Functioning in the Second Phase of the North American Prodrome Longitudinal Study. Jama Psychiatry. PMID 27806157 DOI: 10.1001/Jamapsychiatry.2016.2479 |
0.376 |
|
| 2016 |
Francesconi M, Minichino A, Carrión RE, Chiaie RD, Bevilacqua A, Parisi M, Rullo S, Bersani FS, Biondi M, Cadenhead K. Theory of Mind as a mediator variable between neurocognition and functioning in young individuals in treatment with secondary services for non-psychotic disorders. Psychiatry Research. 246: 415-420. PMID 27788462 DOI: 10.1016/J.Psychres.2016.09.057 |
0.379 |
|
| 2016 |
Cannon TD, Yu C, Addington J, Bearden CE, Cadenhead KS, Cornblatt BA, Heinssen R, Jeffries CD, Mathalon DH, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, et al. An Individualized Risk Calculator for Research in Prodromal Psychosis. The American Journal of Psychiatry. appiajp201615070890. PMID 27363508 DOI: 10.1176/Appi.Ajp.2016.15070890 |
0.304 |
|
| 2016 |
Millard SP, Shofer J, Braff D, Calkins M, Cadenhead K, Freedman R, Green MF, Greenwood TA, Gur R, Gur R, Lazzeroni LC, Light GA, Olincy A, Nuechterlein K, Seidman L, et al. Prioritizing schizophrenia endophenotypes for future genetic studies: An example using data from the COGS-1 family study. Schizophrenia Research. PMID 27132484 DOI: 10.1016/J.Schres.2016.04.011 |
0.379 |
|
| 2016 |
Millan MJ, Andrieux A, Bartzokis G, Cadenhead K, Dazzan P, Fusar-Poli P, Gallinat J, Giedd J, Grayson DR, Heinrichs M, Kahn R, Krebs MO, Leboyer M, Lewis D, Marin O, et al. Altering the course of schizophrenia: progress and perspectives. Nature Reviews. Drug Discovery. PMID 26939910 DOI: 10.1038/Nrd.2016.28 |
0.44 |
|
| 2016 |
Stowkowy J, Liu L, Cadenhead KS, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Bearden CE, Mathalon DH, Addington J. Early traumatic experiences, perceived discrimination and conversion to psychosis in those at clinical high risk for psychosis. Social Psychiatry and Psychiatric Epidemiology. PMID 26851943 DOI: 10.1007/S00127-016-1182-Y |
0.328 |
|
| 2016 |
Mathalon DH, Hamilton H, Bachman P, Belger A, Carrion R, Duncan E, Johannesen J, Niznikiewicz M, Cadenhead K. Mismatch Negativity and Repetition Positivity Predict Transition to Psychosis in Clinical High Risk Individuals International Journal of Psychophysiology. 108: 37. DOI: 10.1016/J.Ijpsycho.2016.07.122 |
0.398 |
|
| 2015 |
Perkins DO, Jeffries CD, Cornblatt BA, Woods SW, Addington J, Bearden CE, Cadenhead KS, Cannon TD, Heinssen R, Mathalon DH, Seidman LJ, Tsuang MT, Walker EF, McGlashan TH. Severity of thought disorder predicts psychosis in persons at clinical high-risk. Schizophrenia Research. PMID 26441004 DOI: 10.1016/J.Schres.2015.09.008 |
0.318 |
|
| 2015 |
Anticevic A, Haut K, Murray JD, Repovs G, Yang GJ, Diehl C, McEwen SC, Bearden CE, Addington J, Goodyear B, Cadenhead KS, Mirzakhanian H, Cornblatt BA, Olvet D, Mathalon DH, et al. Association of Thalamic Dysconnectivity and Conversion to Psychosis in Youth and Young Adults at Elevated Clinical Risk. Jama Psychiatry. PMID 26267151 DOI: 10.1001/Jamapsychiatry.2015.0566 |
0.368 |
|
| 2015 |
Chung Y, Jacobson A, He G, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Walker E, et al. Prodromal Symptom Severity Predicts Accelerated Gray Matter Reduction and Third Ventricle Expansion Among Clinically High Risk Youth Developing Psychotic Disorders. Molecular Neuropsychiatry. 1: 13-22. PMID 26005673 DOI: 10.1159/000371887 |
0.321 |
|
| 2015 |
Cannon TD, Chung Y, He G, Sun D, Jacobson A, van Erp TG, McEwen S, Addington J, Bearden CE, Cadenhead K, Cornblatt B, Mathalon DH, McGlashan T, Perkins D, Jeffries C, et al. Progressive reduction in cortical thickness as psychosis develops: a multisite longitudinal neuroimaging study of youth at elevated clinical risk. Biological Psychiatry. 77: 147-57. PMID 25034946 DOI: 10.1016/J.Biopsych.2014.05.023 |
0.473 |
|
| 2014 |
Solís-Vivanco R, Mondragón-Maya A, León-Ortiz P, Rodríguez-Agudelo Y, Cadenhead KS, de la Fuente-Sandoval C. Mismatch Negativity reduction in the left cortical regions in first-episode psychosis and in individuals at ultra high-risk for psychosis. Schizophrenia Research. 158: 58-63. PMID 25064664 DOI: 10.1016/j.schres.2014.07.009 |
0.301 |
|
| 2014 |
Woods SW, Walsh BC, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Heinssen R, Perkins DO, Seidman LJ, Tarbox SI, Tsuang MT, Walker EF, McGlashan TH. Current status specifiers for patients at clinical high risk for psychosis. Schizophrenia Research. 158: 69-75. PMID 25012147 DOI: 10.1016/J.Schres.2014.06.022 |
0.308 |
|
| 2014 |
Alderman T, Addington J, Bearden C, Cannon TD, Cornblatt BA, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Cadenhead KS. Negative symptoms and impaired social functioning predict later psychosis in Latino youth at clinical high risk in the North American prodromal longitudinal studies consortium. Early Intervention in Psychiatry. PMID 24576057 DOI: 10.1111/Eip.12128 |
0.35 |
|
| 2014 |
Meyer EC, Carrión RE, Cornblatt BA, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Heinssen R, Seidman LJ. The relationship of neurocognition and negative symptoms to social and role functioning over time in individuals at clinical high risk in the first phase of the North American Prodrome Longitudinal Study. Schizophrenia Bulletin. 40: 1452-61. PMID 24550526 DOI: 10.1093/Schbul/Sbt235 |
0.31 |
|
| 2014 |
Tsuang D, Esterberg M, Braff D, Calkins M, Cadenhead K, Dobie D, Freedman R, Green MF, Greenwood T, Gur R, Gur R, Horan W, Lazzeroni LC, Light GA, Millard SP, et al. Is there an association between advanced paternal age and endophenotype deficit levels in schizophrenia? Plos One. 9: e88379. PMID 24523888 DOI: 10.1371/Journal.Pone.0088379 |
0.408 |
|
| 2014 |
Tarbox SI, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Heinssen R, McGlashan TH, Woods SW. Functional development in clinical high risk youth: prediction of schizophrenia versus other psychotic disorders. Psychiatry Research. 215: 52-60. PMID 24200216 DOI: 10.1016/J.Psychres.2013.10.006 |
0.354 |
|
| 2014 |
Cadenhead K, Addington J, Bearden CE, Cannon T, McGlashan T, Mathalon D, Perkins D, Seidman LI, Tsuang M, Walker E, Woods S. Poster #T38 PREDICTION OF SYMPTOM OUTCOME IN CLINICAL HIGH RISK SUBJECTS USING THE ACOUSTIC STARTLE PARADIGM Schizophrenia Research. 153: S302-S303. DOI: 10.1016/S0920-9964(14)70855-2 |
0.38 |
|
| 2013 |
Tarbox SI, Addington J, Cadenhead KS, Cannon TD, Cornblatt BA, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Heinssen R, McGlashan TH, Woods SW. Premorbid functional development and conversion to psychosis in clinical high-risk youths. Development and Psychopathology. 25: 1171-86. PMID 24229556 DOI: 10.1017/S0954579413000448 |
0.311 |
|
| 2013 |
Walder DJ, Holtzman CW, Addington J, Cadenhead K, Tsuang M, Cornblatt B, Cannon TD, McGlashan TH, Woods SW, Perkins DO, Seidman LJ, Heinssen R, Walker EF. Sexual dimorphisms and prediction of conversion in the NAPLS psychosis prodrome. Schizophrenia Research. 144: 43-50. PMID 23340377 DOI: 10.1016/J.Schres.2012.11.039 |
0.368 |
|
| 2012 |
Singh F, Mirzakhanian H, Fusar-Poli P, de la Fuente-Sandoval C, Cadenhead KS. Ethical implications for clinical practice and future research in "at risk" individuals. Current Pharmaceutical Design. 18: 606-12. PMID 22239594 DOI: 10.2174/138161212799316262 |
0.374 |
|
| 2012 |
Cornblatt BA, Carrión RE, Addington J, Seidman L, Walker EF, Cannon TD, Cadenhead KS, McGlashan TH, Perkins DO, Tsuang MT, Woods SW, Heinssen R, Lencz T. Risk factors for psychosis: impaired social and role functioning. Schizophrenia Bulletin. 38: 1247-57. PMID 22080497 DOI: 10.1093/Schbul/Sbr136 |
0.303 |
|
| 2012 |
Bolden KA, Mirza khanian H, Cadenhead K, Eyler LT, Brown GG. Poster #45 WHITE MATTER AND CLINICAL SYMPTOMATOLOGY IN THE EARLY STAGES OF SCHIZOPHRENIA Schizophrenia Research. 136: S107-S108. DOI: 10.1016/S0920-9964(12)70361-4 |
0.359 |
|
| 2011 |
Cadenhead KS. Startle reactivity and prepulse inhibition in prodromal and early psychosis: effects of age, antipsychotics, tobacco and cannabis in a vulnerable population. Psychiatry Research. 188: 208-16. PMID 21555157 DOI: 10.1016/j.psychres.2011.04.011 |
0.312 |
|
| 2011 |
Addington J, Cornblatt BA, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Seidman LJ, Tsuang MT, Walker EF, Woods SW, Heinssen R. At clinical high risk for psychosis: outcome for nonconverters. The American Journal of Psychiatry. 168: 800-5. PMID 21498462 DOI: 10.1176/Appi.Ajp.2011.10081191 |
0.349 |
|
| 2010 |
Kaur T, Cadenhead KS. Treatment implications of the schizophrenia prodrome Current Topics in Behavioral Neurosciences. 4: 97-121. PMID 21312398 DOI: 10.1007/7854_2010_56 |
0.36 |
|
| 2010 |
Seidman LJ, Giuliano AJ, Meyer EC, Addington J, Cadenhead KS, Cannon TD, McGlashan TH, Perkins DO, Tsuang MT, Walker EF, Woods SW, Bearden CE, Christensen BK, Hawkins K, Heaton R, et al. Neuropsychology of the prodrome to psychosis in the NAPLS consortium: relationship to family history and conversion to psychosis. Archives of General Psychiatry. 67: 578-88. PMID 20530007 DOI: 10.1016/J.Schres.2010.02.210 |
0.357 |
|
| 2010 |
Jahchan C, Cadenhead K, Braff D, Light G. NEUROPHYSIOLOGICAL DEFICITS IN PRODROMAL AND RECENT-ONSET SCHIZOPHRENIA Schizophrenia Research. 117: 365-366. DOI: 10.1016/J.Schres.2010.02.647 |
0.374 |
|
| 2010 |
Holtzman CW, Larson MK, Addington J, Cadenhead K, Cannon TD, Cornblatt B, Heinssen R, McGlashan T, Perkins D, Seidman LJ, Tsuang M, Woods SW, Walker EF. SEX DIFFERENCES IN SYMPTOM PRESENTATION IN INDIVIDUALS AT RISK FOR PSYCHOSIS Schizophrenia Research. 117: 304-305. DOI: 10.1016/J.Schres.2010.02.508 |
0.395 |
|
| 2010 |
Addington J, Cornblatt B, Cadenhead K, Cannon T, Heinssen R, McGlashan T, Perkins D, Tsuang M, Walker E, Woods S, Seidman L. CLINICAL HIGH RISK FOR PSYCHOSIS: THE RISK OF FALSE POSITIVE Schizophrenia Research. 117: 279. DOI: 10.1016/J.Schres.2010.02.452 |
0.405 |
|
| 2008 |
Cannon TD, Cadenhead K, Cornblatt B, Woods SW, Addington J, Walker E, Seidman LJ, Perkins D, Tsuang M, McGlashan T, Heinssen R. Prediction of psychosis in youth at high clinical risk: a multisite longitudinal study in North America. Archives of General Psychiatry. 65: 28-37. PMID 18180426 DOI: 10.1001/Archgenpsychiatry.2007.3 |
0.468 |
|
| 2008 |
Ballon JS, Dean KA, Cadenhead KS. Obstetrical complications in people at risk for developing schizophrenia. Schizophrenia Research. 98: 307-11. PMID 17961986 DOI: 10.1016/j.schres.2007.05.011 |
0.319 |
|
| 2007 |
Kristensen K, Cadenhead KS. Cannabis abuse and risk for psychosis in a prodromal sample. Psychiatry Research. 151: 151-4. PMID 17383738 DOI: 10.1016/j.psychres.2006.10.001 |
0.327 |
|
| 2007 |
Swerdlow NR, Sprock J, Light GA, Cadenhead K, Calkins ME, Dobie DJ, Freedman R, Green MF, Greenwood TA, Gur RE, Mintz J, Olincy A, Nuechterlein KH, Radant AD, Schork NJ, et al. Multi-site studies of acoustic startle and prepulse inhibition in humans: initial experience and methodological considerations based on studies by the Consortium on the Genetics of Schizophrenia. Schizophrenia Research. 92: 237-51. PMID 17346930 DOI: 10.1016/J.Schres.2007.01.012 |
0.316 |
|
| 2007 |
Addington J, Cadenhead KS, Cannon TD, Cornblatt B, McGlashan TH, Perkins DO, Seidman LJ, Tsuang M, Walker EF, Woods SW, Heinssen R. North American Prodrome Longitudinal Study: a collaborative multisite approach to prodromal schizophrenia research. Schizophrenia Bulletin. 33: 665-72. PMID 17255119 DOI: 10.1093/Schbul/Sbl075 |
0.328 |
|
| 2005 |
Haroun N, Dunn L, Haroun A, Cadenhead KS. Risk and Protection in Prodromal Schizophrenia: Ethical Implications for Clinical Practice and Future Research Schizophrenia Bulletin. 32: 166-178. PMID 16207892 DOI: 10.1093/Schbul/Sbj007 |
0.312 |
|
| 2005 |
Cadenhead KS, Light GA, Shafer KM, Braff DL. P50 suppression in individuals at risk for schizophrenia: the convergence of clinical, familial, and vulnerability marker risk assessment. Biological Psychiatry. 57: 1504-9. PMID 15953486 DOI: 10.1016/J.Biopsych.2005.03.003 |
0.369 |
|
| 2005 |
Seeber K, Cadenhead KS. How does studying schizotypal personality disorder inform us about the prodrome of schizophrenia? Current Psychiatry Reports. 7: 41-50. PMID 15717986 DOI: 10.1007/s11920-005-0024-5 |
0.345 |
|
| 2003 |
Perry W, Minassian A, Cadenhead K, Sprock J, Braff D. The use of the Ego Impairment Index across the schizophrenia spectrum. Journal of Personality Assessment. 80: 50-7. PMID 12584067 DOI: 10.1207/S15327752Jpa8001_13 |
0.392 |
|
| 2003 |
Cadenhead KS. Vulnerability markers in the schizophrenia spectrum: implications for phenomenology, genetics, and the identification of the schizophrenia prodrome. The Psychiatric Clinics of North America. 25: 837-53. PMID 12462863 DOI: 10.1016/s0193-953x(02)00021-7 |
0.336 |
|
| 2002 |
Granholm E, Cadenhead K, Shafer KM, Filoteo JV. Lateralized perceptual organization deficits on the global-local task in schizotypal personality disorder. Journal of Abnormal Psychology. 111: 42-52. PMID 11866178 DOI: 10.1037/0021-843X.111.1.42 |
0.307 |
|
| 2002 |
Cadenhead KS, Braff DL. Endophenotyping schizotypy: a prelude to genetic studies within the schizophrenia spectrum. Schizophrenia Research. 54: 47-57. PMID 11853978 DOI: 10.1016/S0920-9964(01)00351-6 |
0.304 |
|
| 1996 |
Cadenhead K, Kumar C, Braff D. Clinical and experimental characteristics of "hypothetically psychosis prone" college students. Journal of Psychiatric Research. 30: 331-40. PMID 8923337 DOI: 10.1016/0022-3956(96)00020-9 |
0.378 |
|
| 1993 |
Cadenhead K, Braff D. Do hypothetically psychosis prone college students belong in the schizophrenia spectrum? Schizophrenia Research. 9: 95. DOI: 10.1016/0920-9964(93)90098-4 |
0.324 |
|
| Show low-probability matches. |